Transcription of Packaging ‘blue-box’ requirements and additional ...
{{id}} {{{paragraph}}}
CMDv-GUI-27. EMA/CMDv/391895/2012. Version 22/12/2014. Packaging blue-box' requirements and additional information on labelling/package leaflet for products authorised via national, mutual recognition, decentralised or centralised procedures additional information on labelling/package leaflet that may be required or permitted nationally in accordance with Articles 58 and 64 of Directive 2001/82/EC, as amended, is outlined below. Index AUSTRIA (AT) .. 2. BELGIUM (BE).. 3. BULGARIA (BG) .. 4. CROATIA (HR).. 5. CYPRUS (CY) .. 6. CZECH REPUBLIC (CZ) .. 7. DENMARK (DK) .. 9. ESTONIA (EE) .. 10. FINLAND (FI) .. 11. FRANCE (FR) .. 12. GERMANY (DE) .. 13. GREECE (EL) .. 14. HUNGARY (HU) .. 15. ICELAND (IS) .. 16. IRELAND (IE).. 17. ITALY (IT) .. 18. LATVIA (LV) .. 20. LIECHTENSTEIN (LI) .. 21. LITHUANIA (LT) .. 22. LUXEMBOURG (LU) .. 23. MALTA (MT) .. 24. NETHERLANDS (THE) (NL) .. 25. NORWAY (NO) .. 26. POLAND (PL) .. 27. PORTUGAL (PT).
Legal Status For medicinal products restricted to special prescription (narcotics), a number code assigned by the Minister of Health and a double red line are mandatory.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
On the homeopathic medicinal products, THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER, Draft Guidelines for Manufacturing Homeopathic, Guidelines for Manufacturing Homeopathic Medicines, Directive 2001/83, Medicinal, Guideline on good pharmacovigilance practices, MINISTRY OF HEALTH, Human Medicines Regulations 2012 –, Human Medicines Regulations 2012 – description of